InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Berrey M Michelle, Président de la R&D. Officer active across 1 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 5 disclosures have been published. The latest transaction was filed on 14 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€57,7614,984 shares@ €11.5894100.0% of flow
Common Stock
SEC:0001104659-22-071868:0·
010,300 shares0
Common Stock
SEC:0001104659-22-009551·
010,300 shares0
Common Stock
SEC:0001104659-22-009551:0·
067,118 shares0
Common Stock
SEC:0001104659-21-081624·
067,118 shares0
Common Stock
SEC:0001104659-21-081624:0·
5 of 5 declarations
About Berrey M Michelle
Michelle M. Berrey is President of R&D and Chief Medical Officer of Intercept Pharmaceuticals, Inc. In this role, she oversees the company's research and development initiatives. Michelle brings valuable expertise in the pharmaceutical sector, thereby contributing to the innovation and growth of Intercept Pharmaceuticals. Her commitment to scientific excellence is essential for the company.
